Hancock Jaffe

$8.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
-$0.04 (-0.46%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Hancock Jaffe and other stocks, options, and ETFs commission-free!

About HJLI

Hancock Jaffe Laboratories, Inc. Common Stock, also called Hancock Jaffe, is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA. The listed name for HJLI is Hancock Jaffe Laboratories, Inc. Common Stock.

CEO
Robert Andrew Berman
Employees
12
Headquarters
Irvine, California
Founded
1999
Market Cap
22.15M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
222.36K
High Today
$8.78
Low Today
$8.56
Open Price
$8.73
Volume
96.30K
52 Week High
$20.25
52 Week Low
$5.28

Collections

HJLI Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 17, After Hours

You May Also Like

MSBI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure